Session Abstract – PMWC 2026 Silicon Valley
Track 2
Track Chair: Sam Perli, ThinkHat
Session: AI-Driven Frontiers in Next-Generation Therapeutics
This session explores groundbreaking advancements in AI-driven small molecule discovery, antibody-drug conjugates (ADCs) and sequence medicines including mRNA vaccines and AAVS based gene therapy. Panelists will tackle pressing challenges including integrating large-scale datasets, ensuring model interpretability, and addressing regulatory complexities in AI-based drug development. They’ll also highlight emerging opportunities, including the use of generative AI for drug discovery, personalized medicine, accelerating clinical trials, and improving predictive models for patient outcomes.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
